Prevalence of cachexia in cancer patients

Orellana López, Cristian; Leyton Estéfane, Jose; Ramos Rosales, Miguel; Vásquez RamÍrez, Claudio; Manriquez Arriagada, Claudia; Argilés, Josep M.; López-Soriano, Francisco J.; Ortega-González, Francisco I.; Yañez, Nicolas; Busquets, Silvia

Mostrar el registro sencillo de la publicación

dc.contributor.author	Orellana López, Cristian
dc.contributor.author	Leyton Estéfane, Jose
dc.contributor.author	Ramos Rosales, Miguel
dc.contributor.author	Vásquez RamÍrez, Claudio
dc.contributor.author	Manriquez Arriagada, Claudia
dc.contributor.author	Argilés, Josep M.
dc.contributor.author	López-Soriano, Francisco J.
dc.contributor.author	Ortega-González, Francisco I.
dc.contributor.author	Yañez, Nicolas
dc.contributor.author	Busquets, Silvia
dc.date.accessioned	2023-08-17T18:10:45Z
dc.date.available	2023-08-17T18:10:45Z
dc.date.issued	2023
dc.identifier.uri	http://repositorio.ucm.cl/handle/ucm/4913
dc.description.abstract	Introduction. Cachexia is a syndrome characterized by the loss of musculoskeletal mass, with or without adipose mass, which cannot be reversed by nutritional support. In Chile, there are no data on cachexia in cancer patients that allows for decision making on better interdisciplinary management. In this study, the prevalence of cachexia in inpatient and outpatient cancer patients was investigated. Methods. An observational, descriptive, and cross-sectional study was carried out. Eighty-six inpatients and outpatients were evaluated. Cachexia was evaluated by applying the miniCASCO tool, its weight by bioimpedance, and inflammation by blood parameters. Comparisons and correlations were made considering as the threshold for statistical significance. Results. Forty patients met the inclusion criteria, 35% were men and 65% were women. In all, 27.5% of patients had cachexia secondary to cancer. Of the total number of patients with the syndrome, approximately 45.4% had mild cachexia, 36.3% had severe cachexia, and 18.1% had moderate cachexia. In addition, there was a significant positive correlation and moderately strong (r = 0.7209) match between the final scores and the stage of cancer. Conclusion. The prevalence of cachectic patients is reported for the first time through the application of the miniCASCO tool. A moderate positive match was detected between the final miniCASCO score and the stages of cancer patients. Finally, an early discovery of cachexia would allow therapeutic interventions aimed at improving the prognosis of cancer patients.	es_CL
dc.language.iso	en	es_CL
dc.rights	Atribución-NoComercial-SinDerivadas 3.0 Chile	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/cl/	*
dc.source	European Journal of Cancer Care, 2023, 5743872	es_CL
dc.title	Prevalence of cachexia in cancer patients	es_CL
dc.type	Article	es_CL
dc.ucm.facultad	Facultad de Ciencias de la Salud	es_CL
dc.ucm.indexacion	Scopus	es_CL
dc.ucm.indexacion	Isi	es_CL
dc.ucm.uri	hindawi.com/journals/ejcc/2023/5743872/#abstract	es_CL
dc.ucm.doi	doi.org/10.1155/2023/5743872	es_CL